Universal Health Cl B Earns RS Rating Upgrade

By Investor's Business Daily   |   1 year ago
Universal Health Cl B Earns RS Rating Upgrade

IBD's RS Rating tracks market leadership based on a stock's price performance. Stocks with an RS Rating of 80+ in early stages tend to perform well. Universal Health Cl B is now extended, but watch for a new buying opportunity. Earnings and industry rank are also considered.

Read More

Did you find this insightful?